Phenylketonuria (PKU) Overview
Learn About Phenylketonuria (PKU)
Phenylketonuria (PKU) is a rare genetic metabolic disorder in which the body cannot break down an amino acid called phenylalanine.
To understand the condition, it’s helpful to use an analogy. Think of your body’s metabolism as a series of complex assembly lines in a factory. When you eat protein, it’s broken down into its core components, amino acids, which are like different types of raw materials sent down these lines. One of these materials is phenylalanine (Phe). On a specific assembly line, a dedicated worker, an enzyme called phenylalanine hydroxylase (PAH) has one job: to transform the raw material Phe into another important amino acid called tyrosine.
In a person with PKU, this specific “worker” (the PAH enzyme) is either missing or broken due to a genetic defect. As a result, the assembly line shuts down at that point. This causes two major problems:
- A Toxic Buildup: The raw material, phenylalanine, cannot be processed, so it piles up on the conveyor belt and spills out into the bloodstream, reaching toxic levels. It is this high concentration of Phe that is particularly damaging to the developing brain.
- A Shortage of a Key Product: Because Phe is not being converted, the body cannot produce enough tyrosine. Tyrosine is a crucial building block for several important neurotransmitters (brain chemicals) like dopamine and norepinephrine, and for melanin, the pigment that gives color to skin and hair.
If left untreated, PKU leads to harmful levels of phenylalanine in the blood and brain, potentially causing intellectual disability, behavioral issues, and seizures.
In my experience, early education and dietary support make a world of difference for families. PKU can seem overwhelming at first, but it becomes very manageable with routine.
PKU is caused by a mutation in the PAH gene. This gene, located on chromosome 12, contains the precise set of genetic instructions that tells the body how to make the phenylalanine hydroxylase (PAH) enzyme. A mutation is a change or “spelling error” in these instructions.
When the PAH gene is mutated, the resulting PAH enzyme is either not produced at all or is misshapen and cannot function properly. Without a working PAH enzyme, the body loses its ability to break down phenylalanine. There are many different mutations in the PAH gene that have been identified. The specific type of mutation can determine the severity of the condition. Some mutations trigger an enzyme with a small amount of residual function, leading to milder forms of PKU. Other mutations cause a complete lack of enzyme function, causing classic, severe PKU.
Clinically, I explain that PKU doesn’t come from food or behavior, it’s inherited, and that’s why newborn screening is vital to catch it early before symptoms appear.
You inherit PKU at birth if you receive two defective PAH genes, one from each parent. If only one gene is defective, you’re a carrier but do not develop symptoms.
- A carrier is a person who has one normal copy of the PAH gene and one mutated copy. Carriers do not have PKU themselves because their one normal gene produces enough of the PAH enzyme to process phenylalanine effectively. Most carriers are completely unaware that they have the mutated gene.
When two carriers have a child, there are three possible outcomes for each pregnancy:
- There is a 25% chance that the child will inherit a mutated gene from both parents. This child will have PKU.
- There is a 50% chance that the child will inherit one mutated gene and one normal gene. This child will be an unaffected carrier, just like the parents.
- There is a 25% chance that the child will inherit two normal genes. This child will be completely unaffected and will not be a carrier.
Because PKU is a recessive disorder, the chances of both partners carrying the same rare gene mutation increase in communities where marriage between close relatives (consanguinity) is more common. It is vital to understand that PKU is not caused by anything the parents did during pregnancy. It is a matter of genetic inheritance.
Patients often ask if PKU can be prevented or reversed. I explain it can’t be cured, but it can absolutely be controlled with diet, starting from infancy.
One of the most critical facts about PKU is that newborns with the condition have no symptoms at birth. The damage from PKU only begins to occur after the baby starts consuming protein, either from breast milk or standard infant formula, which both contain phenylalanine. As Phe builds up in the blood, it begins to affect the developing brain.
If left untreated, the signs and symptoms will begin to appear over the first few months of life. These include:
- A musty or “mouse-like” odor in the breath, skin, or urine. This is caused by the buildup of phenylalanine and its byproducts in the body.
- Lighter skin, hair, and eye color than their siblings. Phenylalanine is involved in producing melanin, the pigment responsible for color.
- Skin rashes, such as eczema.
- Microcephaly (an abnormally small head).
- Neurological problems like seizures or tremors.
- Severe developmental delays that become progressively worse.
- Irreversible, severe intellectual disability.
- Behavioral and psychiatric problems, such as hyperactivity, self-injury, and social withdrawal.
The devastating consequences of untreated PKU are the reason why early detection through newborn screening is one of the greatest public health achievements of the last century.
I’ve often heard caregivers say they were shocked when their healthy newborn was diagnosed, early treatment means these babies stay healthy and thrive.
The key to preventing the severe effects of PKU is to diagnose it and start treatment within the first few days of life. This is achieved through newborn screening.
- In many countries, every baby undergoes a routine screening test 24 to 48 hours after birth.
- A healthcare worker performs a simple “heel prick,” taking a few drops of blood from the baby’s heel onto a special filter paper.
- This blood spot card is sent to a laboratory and tested for a panel of rare but serious metabolic disorders, including PKU. The test measures the level of phenylalanine in the blood.
This simple, low-cost screening test is incredibly effective at identifying babies with PKU before they ever show a single symptom.
Clinically, I remind parents that early detection through newborn screening is one of modern medicine’s biggest wins, PKU used to cause widespread disability, now it’s rarely seen when caught early.
If a newborn screening test comes back positive for high phenylalanine levels, it does not automatically mean the baby has PKU. Further testing is required immediately to confirm the diagnosis.
- A repeat blood test will be done to confirm the high Phe level.
- Blood tests will also check the level of tyrosine, which is typically low in PKU.
- Genetic testing can be performed to identify the specific mutations in the PAH gene, which can help predict the severity of the condition and guide treatment.
There is no cure for PKU, but strict lifelong dietary management is essential to prevent complications.
1. The Low-Phenylalanine Diet
This highly restrictive diet is the cornerstone of PKU management. The principle is to limit phenylalanine intake to the absolute minimum amount the body needs for growth, but no more.
- Foods to Eliminate: Because Phe is an amino acid, this is essentially a very low-protein diet. All high-protein foods must be completely eliminated. This includes meat, poultry, fish, eggs, dairy products (milk, cheese, yogurt), nuts, seeds, legumes (beans, lentils), and regular flour, bread, and pasta.
- The Artificial Sweetener Aspartame must also be strictly avoided, as it is made from phenylalanine.
- Allowed Foods: Individuals can generally eat most fruits and vegetables, and special, medically prescribed low-protein breads, pastas, and other foods.
2. The PKU Medical Formula
A person cannot survive on a low-protein diet alone, as they need other amino acids to grow and be healthy. Therefore, the second essential part of treatment is a special PKU medical formula.
- This is a specially designed nutritional drink or powder that contains all the essential amino acids except phenylalanine. It also provides the vitamins, minerals, and calories that are missing from the restricted diet.
- Individuals with PKU must drink this formula every day, for their entire lives, to obtain the nutrition they need without the danger of high Phe levels.
3. Regular Monitoring
Living with PKU requires frequent monitoring of blood Phe levels. This is often done with a finger-prick blood test at home, with samples sent to a lab regularly. The diet and formula are constantly adjusted by a metabolic dietitian based on these levels, the person’s age, and their growth.
4. Newer Treatments
While diet is the primary therapy, some newer medical treatments are available for certain patients:
- Sapropterin dihydrochloride (Kuvan®): This is a medication that can help the faulty PAH enzyme work more effectively in some people with specific, milder mutations. It can help lower blood Phe levels and may allow for a slight relaxation of the diet.
- Enzyme Substitution Therapy (Palynziq®): This is an injectable medication for adults with PKU who are unable to control their Phe levels with diet. It provides a substitute enzyme that breaks down phenylalanine.
I often tell families that PKU is like a marathon, not a sprint. With the right support and routine, most kids with PKU grow up with few limitations.
Maternal PKU
It is critically important for women with PKU to understand the concept of maternal PKU. If a woman with PKU does not maintain a very strict low-Phe diet before and during pregnancy, her high blood Phe levels will cross the placenta and act as a teratogen (an agent that causes birth defects) to her developing baby. This can cause severe intellectual disability, heart defects, and microcephaly in the infant, even if the baby does not inherit PKU.
Phenylketonuria is a serious inherited disorder that, if left to its own devices, has devastating consequences for brain development. Yet, it stands as a shining example of the power of modern medicine and public health. Through the simple heel prick of a newborn screening test, this condition can be caught in the first days of life. With a lifelong commitment to a carefully managed low-protein diet and specialized medical formula, the toxic buildup of phenylalanine can be prevented entirely. This “diet for life” is undoubtedly challenging, requiring immense discipline from individuals and families. Patients and families often share that, while the diagnosis was overwhelming at first, the right education and support made managing PKU a structured, empowering part of life.
Mayo Clinic. (2022). Phenylketonuria (PKU). Retrieved from https://www.mayoclinic.org/diseases-conditions/phenylketonuria/symptoms-causes/syc-20376302
National Institute of Child Health and Human Development (NICHD). (2021). Phenylketonuria (PKU). Retrieved from https://www.nichd.nih.gov/health/topics/pku
National Organization for Rare Disorders (NORD). (2023). Phenylketonuria. Retrieved from https://rarediseases.org/rare-diseases/phenylketonuria/
University Professional Services
Cary Harding is a Medical Genetics specialist and a Pediatrics provider in Portland, Oregon. Dr. Harding is rated as an Elite provider by MediFind in the treatment of Phenylketonuria (PKU). His top areas of expertise are Phenylketonuria (PKU), Urea Cycle Disorders (UCD), Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, and Hepatectomy. Dr. Harding is currently accepting new patients.
Barbara Burton is a Medical Genetics specialist and a Pediatrics provider in Chicago, Illinois. Dr. Burton is rated as an Elite provider by MediFind in the treatment of Phenylketonuria (PKU). Her top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Cholesteryl Ester Storage Disease.
Ania Muntau practices in Hamburg, Germany. Ms. Muntau is rated as an Elite expert by MediFind in the treatment of Phenylketonuria (PKU). Her top areas of expertise are Phenylketonuria (PKU), Maternal Hyperphenylalaninemia, Glutaric Acidemia Type 1, Liver Transplant, and Microvascular Decompression.
Summary: The main purpose of this trial is to evaluate the long-term efficacy of sepiapterin on preserving neurocognitive functioning in children with PKU when treatment is initiated in early childhood.
Summary: PKU UP is a prospective, single-arm, open-label, 26-week acceptability study to evaluate PKU UP for the dietary management of participants with phenylketonuria (PKU). Up to 15 participants aged 1 - 10 years old will be recruited and it is anticipated the study will open in at least three sites in the United Kingdom (UK) to recruit the target number of participants in the required timeframe.